Sensex
84,950.95 profit arw 388.17 (0.46%)
Nifty
26,013.45 profit arw 103.40 (0.40%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 17-Nov-2025
Corporate News
17-Nov-2025     09:38

USFDA completes specific Pre Approval Inspection of Lupin's Unit 1 in Nagpur

Lupin announced that the United States Food and Drug Administration (U.S. FDA) has completed a product specific Pre Approval Inspection at its Unit-1 oral solid dosage manufacturing facility in Nagpur. The inspection was carried out from 10 November to 14 November 2025, and concluded with zero 483 observations.

Nilesh Gupta, Managing Director, Lupin said, 'The successful outcome of the U.S. FDA inspection at our Nagpur Unit-1 facility exemplifies our commitment to uphold and maintain the highest standards of quality, compliance, and safety across our facilities. We remain dedicated to improving the lives of our patients globally.'

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

84,950.95 388.17 (0.46%)

Nifty

26,013.45 103.40 (0.40%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,384.29 -188.18(-0.71%)